ω-3 polyunsaturated fatty acid supplementation ameliorates lipopolysaccharide-induced behavioral deficits and modulates neurotrophic factors in rats: Focus on tPA/PAI-1 system and BDNF-TrkB signaling

[1]  E. Castrén,et al.  Brain-derived neurotrophic factor in mood disorders and antidepressant treatments , 2017, Neurobiology of Disease.

[2]  Zhijun Zhang,et al.  Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies , 2016, Scientific Reports.

[3]  Yujin Guo,et al.  Quantitative profiling of neurotransmitter abnormalities in the hippocampus of rats treated with lipopolysaccharide: Focusing on kynurenine pathway and implications for depression , 2016, Journal of Neuroimmunology.

[4]  M. Yepes Tissue-type plasminogen activator is a neuroprotectant in the central nervous system , 2015, Front. Cell. Neurosci..

[5]  C. Shin,et al.  The Role of TLR4 and Fyn Interaction on Lipopolysaccharide-Stimulated PAI-1 Expression in Astrocytes , 2015, Molecular Neurobiology.

[6]  J. Cheong,et al.  Propofol treatment modulates neurite extension regulated by immunologically challenged rat primary astrocytes: a possible role of PAI-1 , 2015, Archives of pharmacal research.

[7]  A. Nadjar,et al.  Transgenic Increase in n-3/n-6 Fatty Acid Ratio Protects Against Cognitive Deficits Induced by an Immune Challenge through Decrease of Neuroinflammation , 2015, Neuropsychopharmacology.

[8]  H. Gong,et al.  Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system , 2015, Physiology & Behavior.

[9]  Wen-Ye Zhu,et al.  The Impacts of Swimming Exercise on Hippocampal Expression of Neurotrophic Factors in Rats Exposed to Chronic Unpredictable Mild Stress , 2014, Evidence-based complementary and alternative medicine : eCAM.

[10]  E. Rostrup,et al.  The effect of exercise on hippocampal volume and neurotrophines in patients with major depression--a randomized clinical trial. , 2014, Journal of affective disorders.

[11]  J. Quevedo,et al.  Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice , 2014, Neuroscience.

[12]  J. Zhang,et al.  Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice , 2014, Neuroscience.

[13]  R. Dantzer,et al.  NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice , 2013, Neuropsychopharmacology.

[14]  B. Levant N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence. , 2013, CNS & neurological disorders drug targets.

[15]  C. Kuan,et al.  Plasminogen activator inhibitor-1 mitigates brain injury in a rat model of infection-sensitized neonatal hypoxia-ischemia. , 2013, Cerebral cortex.

[16]  E. Obuchowicz,et al.  BDNF and VEGF in the pathogenesis of stress-induced affective diseases: An insight from experimental studies , 2013, Pharmacological reports : PR.

[17]  S. Yamawaki,et al.  Electroconvulsive seizure, but not imipramine, rapidly up-regulates pro-BDNF and t-PA, leading to mature BDNF production, in the rat hippocampus. , 2013, The international journal of neuropsychopharmacology.

[18]  A. Bahi,et al.  Hippocampus-specific deletion of tissue plasminogen activator “tPA” in adult mice impairs depression- and anxiety-like behaviors , 2012, European Neuropsychopharmacology.

[19]  Lisa Goehler,et al.  In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  E. Tongiorgi,et al.  The antidepressive effect of the physical exercise correlates with increased levels of mature BDNF, and proBDNF proteolytic cleavage-related genes, p11 and tPA , 2011, Neuroscience.

[21]  Yonggui Yuan,et al.  Plasma BDNF and tPA are associated with late‐onset geriatric depression , 2010, Psychiatry and clinical neurosciences.

[22]  Cai Song,et al.  Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin‐1β administrations: effects of omega‐3 fatty acid EPA treatment , 2010, Journal of neurochemistry.

[23]  H. Schmidt,et al.  Future Antidepressant Targets: Neurotrophic Factors and Related Signaling Cascades. , 2008, Drug discovery today. Therapeutic strategies.

[24]  T. Hamazaki,et al.  Dietary n-3 fatty acids selectively attenuate LPS-induced behavioral depression in mice , 2004, Physiology & Behavior.